NCT06401902

Brief Summary

Diabetes in an independent risk factor for ischemic stroke, whose associated mortality rate is higher and sequelae more serious than for nondiabetics. Diabetes increases the risk of stroke or death after surgical carotid revascularization or endoluminal angioplasty. It is, with contralateral ICA occlusion, 1 of the 7 factors doubling the stroke risk after carotid endarterectomy. Diabetes also enhances the cerebral hemorrhage risk associated with carotid surgery, thrombectomy or thrombolysis revascularization of the cerebral arteries. This study was undertaken to examine whether the hemodynamic cerebral ischemia (HCI) frequency, which increases stroke severity, is higher in diabetics than nondiabetics and, if diabetes carries an excess HCI risk, whether it is independent of contralateral ICA occlusion.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,739

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 1990

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 1990

Completed
29.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2019

Completed
4.8 years until next milestone

First Submitted

Initial submission to the registry

May 2, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 7, 2024

Completed
Last Updated

May 7, 2024

Status Verified

May 1, 2024

Enrollment Period

29.5 years

First QC Date

May 2, 2024

Last Update Submit

May 2, 2024

Conditions

Keywords

diabetesischemic strokecerebral hemorrhagehypoperfusionhyperperfusion

Outcome Measures

Primary Outcomes (3)

  • Intolerance to carotid clamping test

    Occurrence of consciousness perturbations: patient loses consciousness

    During clamping test

  • Intolerance to carotid clamping test.

    Language difficulties: the patient no longer answers questions

    During clamping test

  • Intolerance to carotid clamping test.

    Contralateral motor deficit: anesthesiologist request to shake hands.

    During clamping test

Study Arms (2)

Diabetics

Diabetics patients who underwent internal carotid artery surgery

Procedure: carotid clamping

Nondiabetics

Nondiabetics patients who underwent internal carotid artery surgery

Procedure: carotid clamping

Interventions

Occurrence of consciousness perturbations, language difficulties and/or contralateral motor deficit during the carotid-clamping test and requiring shunt placement.

DiabeticsNondiabetics

Eligibility Criteria

Age28 Years - 97 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with carotid stenosis requiring carotid surgery.

You may qualify if:

  • Patients with clamping test during carotid surgery.

You may not qualify if:

  • Patients without clamping test during carotid surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mutualist Montsouris Institute

Paris, Île-de-France Region, 75014, France

Location

MeSH Terms

Conditions

Carotid StenosisDiabetes MellitusIschemic StrokeCerebral Hemorrhage

Condition Hierarchy (Ancestors)

Carotid Artery DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesStrokeIntracranial HemorrhagesHemorrhagePathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Christian Pr PETITJEAN

    Institut Mutualiste Montsouris

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 2, 2024

First Posted

May 7, 2024

Study Start

January 1, 1990

Primary Completion

June 30, 2019

Study Completion

June 30, 2019

Last Updated

May 7, 2024

Record last verified: 2024-05

Locations